Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1993-09-14
1996-12-17
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
514 2, 514 8, 514 12, A61K 3848, A61K 3802, A61K 3816, A61K 3836
Patent
active
055850952
ABSTRACT:
A method of inhibiting blood coagulation in a patient is provided. This method involves administering to the patient an effective anticoagulant amount of a cationic protein; wherein the cationic protein has an isoelectric point of at least about 7.4, and is capable of enhancing the production of activated protein C by a thrombomodulin-thrombin complex by a factor of at least about two. A particularly preferred cationic protein is purified Platelet Factor 4.
REFERENCES:
patent: 5086164 (1992-02-01), Maione et al.
patent: 5112946 (1992-05-01), Maione
patent: 5196322 (1993-03-01), Bang et al.
patent: 5204321 (1993-04-01), Cook et al.
M.-C. Bourin et al., "Relationship between Anticoagulant Activities and Polyanionic Properties of Rabbit Thrombomodulin", J. Biol. Chem., 263, 8044-8052 (1988).
M.-C. Bourin et al., "Isolation and Characterization of the Glycosaminoglycan Component of Rabbit Thrombomodulin Proteoglycan", J. Biol. Chem., 265, 15424-15431 (1990).
T. F. Deuel et al., "Amino acid sequence of human platelet factor 4", Proc. Natl. Acad. Sci. USA, 74, 2256-2258 (1977).
W. A. Dittman et al., "Structure and Function of Thrombomodulin: A Natural Anticoagulant", Blood, 75, 329-336 (1990).
C. T. Esmon, "The Roles of Protein C and thrombomodulin in the Regulation of Blood Coagulation", J. Biol. Chem., 264, 4743-4746 (1989).
N. L. Esmon et al., "Isolation of a Membrane-bound Cofactor for Thrombin-catalyzed Activation of Protein C", J. Biol. Chem., 257, 859-864 (1982).
C. B. Glaser et al., "Oxidation of a Specific Methionine in Thrombomodulin by Activated Neutrophil Products Blocks Cofactor Activity", J. Clin. Invest., 90, 2565-2573 (1992).
J. H. Griffin et al, "Deficiency of Protein C in Congenital Thrombotic Disease", J. Clin. Invest., 68, 1370 (1981).
S. Kurosawa et al., "Proteolytic Formation and Properties of Functional Domains of Thrombomodulin", J. Biol. Chem., 262, 2206-2212 (1987).
R. Michalski et al., "Neutralization of Heparin in Plasma by Platelet Factor 4 and Protamine Sulphate", Brit. J. Haematol., 38, 561-571 (1978).
K. Nawa et al., "Presence and Function of Chondroitin-4-Sulfate on Recombinant Human Soluble Thrombomodulin", Biochem. Biophys. Res. Commun., 171, 729-737 (1990).
K. Nawa et al., "The Glycosaminoglycan of Recombinant Human Soluble Thrombomodulin Affects Antithrombotic Activity in a Rat Model of Tissue Factor-Induced Disseminated Intravascular Coagulation", Thrombosis and Hemostasis, 66, 366-370 (1992).
J. F. Parkinson et al., "Stable Expression of a Secretable Deletion Mutant of Recombinant Human Thrombomodulin in Mammalian Cells", J. Biol. Chem., 265, 12602-12610 (1990).
J. F. Parkinson et al., "Recombinant human thrombomodulin", Biochem. J., 283, 151-157 (1992).
K. T. Preissner et al., "Domain Structure of the Endothelial Cell Receptor Thrombomodulin as Deduced from Modulation of Its Anticoagulant Functions", J. Biol. Chem., 265, 4915-4922 (1990).
U. Seligsohn et al., "Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the Newborn", N. Engl. J. Med., 310, 559 (1984).
A. Slungaard et al., "Bromide-dependent Toxicity of Eosinophil Peroxidase for Endothelium and Isolated Working Rat Hearts" A Model for Eosinophilic Endocarditis, J. Exp. Med., 173, 117-126 (1991).
A. Slungaard et al., "Eosinophil Cationic Granule Proteins Impair Thrombomodulin Function", J. Clin. Invest., 91, 1721-1730 (1993).
F. B. Taylor et al., "Protein C Prevents the Coagulopathic and Lethal Effects of Escherichia coli Infusion in the Baboon", J. Clin. Invest., 79, 918-925 (1987).
M. B. Zucker et al., "Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action", Proc. Soc. Exp. Biol. Med., 198, 693-702 (1991).
Bourin, M.-C. et al. (1988) "Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin" J. Biol. Chem 263(17):8044-8052.
Preissner, K. T. et al. (1990) "Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions" J. Biol. Chem 265(9):4915-4922.
Lau Kawai
Regents of the University of Minnesota
Wax Robert A.
LandOfFree
Method to enhance thrombomodulin APC generation using cationic p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to enhance thrombomodulin APC generation using cationic p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to enhance thrombomodulin APC generation using cationic p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1989276